EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson’s Disease

Prevalence of Dyskinesia and OFF by 30-Minute Intervals Through the Day and Assessment of Daily Episodes of Dyskinesia and OFF: Novel Analyses of Diary Data from Gocovri Pivotal Trials

(2019) Robert A. Hauser et al.   Journal of Parkinsons Disease

Pharmacokinetics of ADS-5102 (Amantadine) Extended Release Capsules Administered Once Daily at Bedtime for the Treatment of Dyskinesia

(2018) Robert A. Hauser et al.   CLINICAL PHARMACOKINETICS

Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease

(2018) Lawrence W. Elmer et al.   CNS DRUGS

Author Correction to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease

(2018) Lawrence W. Elmer et al.   CNS DRUGS

Minimal clinically important difference for the historic parts of the Unified Dyskinesia Rating Scale

(2018) Attila Makkos et al.   PARKINSONISM & RELATED DISORDERS

Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3)

(2017) Wolfgang Oertel et al.   MOVEMENT DISORDERS

ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson’s Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety Study

(2017) Robert A. Hauser et al.   Journal of Parkinsons Disease

ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study)

(2017) Rajesh Pahwa et al.   JAMA Neurology

Psychosis in Parkinson’s Disease: Epidemiology, Pathophysiology, and Management

(2016) Anna Chang et al.   DRUGS

Falls in ambulatory non-demented patients with Parkinson’s disease

(2015) Olivier Rascol et al.   JOURNAL OF NEURAL TRANSMISSION

Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study)

(2015) Rajesh Pahwa et al.   MOVEMENT DISORDERS

Natural history of falls in a population-based cohort of patients with Parkinson's disease: An 8-year prospective study

(2014) Ylva Hivand Hiorth et al.   PARKINSONISM & RELATED DISORDERS

Pharmacology of Hallucinations: Several Mechanisms for One Single Symptom?

(2014) Benjamin Rolland et al.   Biomed Research International

Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis

(2013) Kate Merritt et al.   Frontiers in Psychiatry

A 12-Year Population-Based Study of Psychosis in Parkinson Disease

(2010) Elin B. Forsaa et al.   ARCHIVES OF NEUROLOGY

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

(2008) Christopher G. Goetz et al.   MOVEMENT DISORDERS